JPRN-UMIN000012042招募中未知
Phase 2 study of S-1, docetaxel, cisplatin and trastuzumab combination chemotherapy (DCS-T) in patients with HER2-positive unresectable metastatic gastric cancer - Phase 2 study of DCS-T for HER2-positive unresectable metastatic gastric cancer
Tokushima-Hokkaido cancer therapy clinical trial group0 个研究点目标入组 30 人开始时间: 2013年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of hypersensitivity to DCS. 2)Contraindication to TXT, CDDP, S-1, G-CSF. 3)Infectious disease. 4)Severe compliaction. 5)Neuropathy greater than grade 2. 6)Brain metastasis with clinical symptoms. 7)Watery diarea. 8)Active double cancer. 9)Persons to be pregnant or to make pregnant.
研究者
相似试验
招募中
2 期
Phase II study of DCS-Tgastric cancerJPRN-jRCTs061180096Takayama Tetsuji30
已完成
1 期
Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Canceruntreated advanced or recurrent gastric cancerJPRN-UMIN000000484Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama40
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18
招募中
2 期
Phase II study of Docetaxel, Cisplatin and S1 followed by surgery in advanced gastric cancer with lymph node metastasis of the paraaortagastric cancer with para-aortic lymph node metastasisJPRN-UMIN000006036Digestive Disease Support Organization (DDSO)30
招募中
2 期
Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.Gastric cancerJPRN-UMIN000002361Tokushima-Hokkaido cancer therapy clinical trial group50